**
The recent outbreak of cyclosporiasis in the United States, attributed to the parasite *Cyclospora cayetanensis*, has grown alarmingly, with over 18,000 suspected and confirmed cases reported by late July. However, the manufacturer of a widely used laboratory test suggests there may be a decline in infection rates. While public health officials remain vigilant, the complexities surrounding testing and reporting raise important questions about the true extent of the outbreak.
Current Status of the Outbreak
In what is now the largest recorded outbreak of cyclosporiasis in the U.S., the Midwest has seen significant numbers of infections across nine states, primarily linked to iceberg lettuce imported from Taylor Farms in Mexico. The Centers for Disease Control and Prevention (CDC) has confirmed 6,707 cases, with an additional 11,500 cases pending further investigation. The surge in cases, particularly notable during the summer months when such infections typically rise, has prompted extensive public health efforts to manage and understand the situation.
John Osiecki, Vice-President of Medical Affairs at bioMerieux, a French diagnostics company, expressed cautious optimism regarding a potential decline in positivity rates for cyclosporiasis testing. However, he acknowledged that the increase in testing due to heightened public awareness could skew the positivity statistics. “I’m feeling confident we’re heading in that direction, but we need to continue to monitor this as we go forward,” he stated.
The Role of Testing in Understanding the Outbreak
Data from bioMerieux’s Syndromic Trends indicates that the positivity rate for illnesses involving parasites peaked at 15.6% in mid-July, a significant outlier compared to the 2.9% positivity rate observed during the same period in 2025. This spike raises concerns about the reliability of the data, as it reflects not only the outbreak’s severity but also the impact of increased public awareness leading to more individuals seeking testing.
Nevertheless, Osiecki believes that the societal shift towards avoiding lettuce due to the outbreak could contribute to a genuine decline in new infections. He noted, “I’ve been in a lot of social settings, and I’ve heard people request not to have lettuce just because they’re aware of cyclospora.” This awareness is critical in mitigating the spread, but it also highlights the need for accurate and comprehensive data collection by health authorities.
Ongoing Investigations and Future Implications
Despite indications of a potential slowdown, food safety researchers caution that the outbreak may be more extensive than currently documented. The Food and Drug Administration (FDA) is actively investigating multiple outbreaks, with no clear source identified in all cases. In New Hampshire, cases linked to Taylor Farms lettuce have emerged, underscoring the widespread distribution of the contaminated product, which was reportedly sold across 27 states.
Furthermore, bioMerieux’s testing panel, which screens for various gastrointestinal parasites, is only covered by Medicare for immunosuppressed patients, limiting access to the tests for broader populations. The cost of the test, which stands at $417, further complicates the ability of individuals, particularly in rural areas, to obtain timely diagnoses.
Why it Matters
The cyclosporiasis outbreak serves as a stark reminder of the intricate relationship between food safety and public health. As thousands continue to grapple with infection, the ongoing investigation and the need for transparent data collection are paramount to understanding and addressing the outbreak effectively. Public awareness has undeniably increased, yet the potential for underreported cases remains a significant concern. As health officials strive to contain the situation, it is essential that both the medical community and the public remain informed and engaged in preventive measures to avert further outbreaks.
